This year’s JP Morgan struck a different tone than previous years—a very pleasant one, despite higher security anxieties ...

The four-day conference drew roughly 8,000 attendees and featured presentations from more than 500 private and public ...

What are biopharma VCs looking to invest in this year? Autoimmune disorders, osteoporosis, and cardiovascular disease are ...

Potential antitrust deregulation could foster a more favourable environment for larger M&A deals in 2025, though skepticism ...

Reminders of the killing of UnitedHealthcare CEO Brian Thompson were everywhere at this year's J.P. Morgan conference.

Check out who's buying and selling in this week's roundup of healthcare mergers, acquisitions and joint ventures.

As the J.P. Morgan Healthcare Conference started in San Francisco on Monday, AbbVie linked up with Simcere with a $1 billion ...

At the JP Morgan Conference 2025, CEO Chen said the potential of the Biosecure Act passing has had only a minimal chilling ...

Six out of 31 total new small molecules approved by the FDA in 2024 were produced by Wuxi, said the company's co-CEO.

San Francisco law enforcement and city leaders are gearing up for a big month ahead and are warning people to be on alert for ...